Gordon Samson, President, Intellectual Property, provides a virtual update on strategy and generative AI initiatives
London, UK – March 20, 2024 Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today the launch of the third and final video in a series of Clarivate in the Age of AI webinar presentations led by the Presidents of its three segments: Academia & Government, Life Sciences & Healthcare and Intellectual Property.
The Intellectual Property (IP) video presentation highlights how Clarivate plays an important role in the IP ecosystem by serving as an indispensable partner to more than 20,000 customers. Clarivate is deeply entrenched across the global IP landscape supporting some of the most critical, non-discretionary tasks in the IP process. Gordon Samson, President, Intellectual Property, discusses the business strategy, how we intend to align our portfolio to the market growth rate, and our artificial intelligence strategy to add more value to our customers. The presentation concludes with three of our product leaders sharing demos of our recent Generative AI innovations.
Samson said: “The growth in intellectual property filings, globalization, and changes in country laws and regulations has increased the complexity of managing all aspects of the IP process. Our cloud-based and on-premises IP management software and managed services help our clients streamline and automate their portfolio management processes, freeing time for strategic activity and decision-making. We have laid the groundwork to deliver greater value to our customers and set ourselves up for improving sustainable growth.”
The Intellectual Property video webinar as well as the previously released Academia & Government and Life Sciences & Healthcare webinars can be accessed HERE.
You may also like…
Is your foreign filing patent strategy stuck in 2010?
Ask any in-house IP team how they handle foreign patent filings, and the answer is usually some version of the same...
Buying speed: IP acquisitions in the age of AI code generation
Public and private market investors demand double-digit growth from enterprise and business-to-business (B2B) software...
Protecting innovation and unlocking opportunity in the biologics market
Biologics now account for roughly 42% of total pharmaceutical sales globally, and some analysts expect them to outpace...











